12:00 AM
 | 
Jun 18, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Actilyse regulatory update

The Scottish Medicines Consortium recommended the use of Actilyse alteplase from Boehringer on the National Health Service (NHS) in Scotland to treat acute ischemic stroke up to 4.5 hours after onset of stroke symptoms and after prior...

Read the full 161 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >